424 related articles for article (PubMed ID: 31297668)
21. Development of an agar-based screening method for terbinafine, itraconazole, and amorolfine susceptibility testing of
Siopi M; Efstathiou I; Arendrup MC; Meletiadis J
J Clin Microbiol; 2024 Jan; 62(1):e0130823. PubMed ID: 38117081
[TBL] [Abstract][Full Text] [Related]
22. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
Koc AN; Silici S; Ayangil D; Ferahbaş A; Cankaya S
Mycoses; 2005 May; 48(3):205-10. PubMed ID: 15842339
[TBL] [Abstract][Full Text] [Related]
23. Disk diffusion susceptibility testing of dermatophytes with allylamines.
Venugopal PV; Venugopal TV
Int J Dermatol; 1994 Oct; 33(10):730-2. PubMed ID: 8002146
[TBL] [Abstract][Full Text] [Related]
24. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates.
Jessup CJ; Warner J; Isham N; Hasan I; Ghannoum MA
J Clin Microbiol; 2000 Jan; 38(1):341-4. PubMed ID: 10618112
[TBL] [Abstract][Full Text] [Related]
25. Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Salehi Z; Fatahi N; Taran M; Izadi A; Badali H; Hashemi SJ; Rezaie S; Daie Ghazvini R; Ghaffari M; Aala F; Barac A; Khodavaisy S
J Mycol Med; 2020 Jun; 30(2):100935. PubMed ID: 32139093
[TBL] [Abstract][Full Text] [Related]
26. [In vitro activities of antifungal drugs against clinical isolates of Trichophyton tonsurans].
Koga H; Nanjoh Y; Inoue K; Makimura K; Tsuboi R
Nihon Ishinkin Gakkai Zasshi; 2006; 47(4):299-304. PubMed ID: 17086163
[TBL] [Abstract][Full Text] [Related]
27. Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates.
Salehi Z; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1841-1846. PubMed ID: 29980898
[TBL] [Abstract][Full Text] [Related]
28. Invitro Activity of Four Commonly Available Antifungal Drugs against Dermatophytes Species Isolated From Clinical Samples Using Disk Diffusion Method in Mymensingh.
Monwar S; Begum H; Boby F
Mymensingh Med J; 2020 Apr; 29(2):420-423. PubMed ID: 32506099
[TBL] [Abstract][Full Text] [Related]
29. A novel method using micropig stratum corneum in vitro for the evaluation of anti-Trichophyton mentagrophytes activity.
Nakashima T; Nozawa A; Majima T
Microbiol Immunol; 2002; 46(8):521-5. PubMed ID: 12363015
[TBL] [Abstract][Full Text] [Related]
30. Antifungal susceptibility testing of Trichophyton rubrum by E-test.
da Silva Barros ME; de Assis Santos D; Soares Hamdan J
Arch Dermatol Res; 2007 May; 299(2):107-9. PubMed ID: 17333224
[TBL] [Abstract][Full Text] [Related]
31. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
32. A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: Genomic insights and resistance profile.
Singh A; Masih A; Monroy-Nieto J; Singh PK; Bowers J; Travis J; Khurana A; Engelthaler DM; Meis JF; Chowdhary A
Fungal Genet Biol; 2019 Dec; 133():103266. PubMed ID: 31491507
[TBL] [Abstract][Full Text] [Related]
33. Antifungal susceptibility and virulence factors of clinically isolated dermatophytes in Tehran, Iran.
Afshari MA; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
Iran J Microbiol; 2016 Feb; 8(1):36-46. PubMed ID: 27092223
[TBL] [Abstract][Full Text] [Related]
34. Terbinafine susceptibility and genotypic heterogeneity in clinical isolates of Trichophyton mentagrophytes by random amplified polymorphic DNA (RAPD).
Alipour M; Mozafari NA
J Mycol Med; 2015 Mar; 25(1):e1-9. PubMed ID: 25649232
[TBL] [Abstract][Full Text] [Related]
35. In Vitro Antifungal Activity of Green Synthesized Silver Nanoparticles in Comparison to Conventional Antifungal Drugs Against Trichophyton Interdigitale, Trichophyton Rubrum and Epidermophyton Floccosum.
Mahmoudi S; Vahidi M; Malekabad ES; Izadi A; Khatami M; Dadashi A
Infect Disord Drug Targets; 2021; 21(3):370-374. PubMed ID: 32669080
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes.
Singh J; Zaman M; Gupta AK
Med Mycol; 2007 Nov; 45(7):595-602. PubMed ID: 17885958
[TBL] [Abstract][Full Text] [Related]
37. Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes.
Méndez CC; Serrano MC; Valverde A; Pemán J; Almeida C; Martín-Mazuelos E
Med Mycol; 2008 Mar; 46(2):119-23. PubMed ID: 18324490
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the antifungal potential of linalool against clinical isolates of fluconazole resistant Trichophyton rubrum.
de Oliveira Lima MI; Araújo de Medeiros AC; Souza Silva KV; Cardoso GN; de Oliveira Lima E; de Oliveira Pereira F
J Mycol Med; 2017 Jun; 27(2):195-202. PubMed ID: 28189377
[TBL] [Abstract][Full Text] [Related]
39. Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor.
Carreira A; Ferreira JB; Pereira I; Ferreira J; Filipe P; Ferreira RB; Monteiro S
J Med Microbiol; 2018 Feb; 67(2):198-207. PubMed ID: 29388537
[TBL] [Abstract][Full Text] [Related]
40. Phylogeny, Antifungal Susceptibility, and Point Mutations of
Pashootan N; Shams-Ghahfarokhi M; Chaichi Nusrati A; Salehi Z; Asmar M; Razzaghi-Abyaneh M
Front Cell Infect Microbiol; 2022; 12():851769. PubMed ID: 35372131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
